| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Thompson Health is committed to providing quality health care to our community. Part of that commitment, includes providing information which will enable you to make informed health care decisions.
Le Tourneau Prosthetics is a Beaumont, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
War Memorial Hospital is a Sault Sainte Marie, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FOR ALMOST TWO DECADES, MARKWINS INTERNATIONAL has been providing expertly designed cosmetic and beauty care collections.